Daniel Price, one of PEARRL’s Early Stage Researchers has published his first scientific paper as lead author in Chemical Communications this month entitled “Poly(amino acid)-polyester graft copolymer nanoparticles for the acid-mediated release of doxorubicin”. This research was carried out at the School of Chemistry, University of Leeds, before Daniel joined Merck and the PEARRL project for his PhD studies.

An open symposium on ‘Regulatory Support of Innovation in the Pharmaceutical Industry' on 21st June 2017 as part of the first Annual PEARRLS of Wisdom Week in Cork, Ireland http://www.pearrl.eu/rss2017.html.  PEARRL is a European Training Network (ETN) that brings together partners from European pharmaceutical industry, academia and regulatory agencies as a multi-sectorial team to deliver collaborative research and training network focused on accelerating the development and approval of breakthrough therapy drugs.